From engineered heart tissue to cardiac organoid

Jaeyeaon Cho, Hyein Lee, Woongchan Rah, Hyuk Jae Chang, Young Sup Yoon

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


The advent of human pluripotent stem cells (hPSCs) presented a new paradigm to employ hPSC-derived cardiomyocytes (hPSC-CMs) in drug screening and disease modeling. However, hPSC-CMs differentiated in conventional two-dimensional systems are structurally and functionally immature. Moreover, these differentiation systems generate predominantly one type of cell. Since the heart includes not only CMs but other cell types, such monolayer cultures have limitations in simulating the native heart. Accordingly, three-dimensional (3D) cardiac tissues have been developed as a better platform by including various cardiac cell types and extracellular matrices. Two advances were made for 3D cardiac tissue generation. One type is engineered heart tissues (EHTs), which are constructed by 3D cell culture of cardiac cells using an engineering technology. This system provides a convenient real-time analysis of cardiac function, as well as a precise control of the input/output flow and mechanical/electrical stimulation. The other type is cardiac organoids, which are formed through self-organization of differentiating cardiac lineage cells from hPSCs. While mature cardiac organoids are more desirable, at present only primitive forms of organoids are available. In this review, we discuss various models of hEHTs and cardiac organoids emulating the human heart, focusing on their unique features, utility, and limitations.

Original languageEnglish
Pages (from-to)2758-2772
Number of pages15
Issue number6
Publication statusPublished - 2022

Bibliographical note

Funding Information:
This work was supported by National Research Foundation of Korea (NRF) funded by the Korean government (MSIT) (No. 2020R1A2C3003784, No.2020M3A9I4038454), the Faculty Research Assistance Program of Yonsei University College of Medicine (6-2020-0184), the Parts/Materials Development Project in 2021 (20016564) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea), the Brain Korea 21 Project for Medical Science, Yonsei University and by grants from NHLBI (R01HL150877, R01HL156008), American Heart Association Transformational Project Award (20TPA35490282).

Publisher Copyright:
© The author(s)

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)


Dive into the research topics of 'From engineered heart tissue to cardiac organoid'. Together they form a unique fingerprint.

Cite this